528-04-1 (尿苷 5'-(2-乙酰氨基-2-脱氧-ALPHA-D-葡糖基焦磷酸酯),Uridine 5'-(trihydrogendiphosphate), P'-[2-(acetylamino)-2-deoxy-a-D-glucopyranosyl] ester)

CAS号:
528-04-1
中文名称:
尿苷 5'-(2-乙酰氨基-2-脱氧-ALPHA-D-葡糖基焦磷酸酯)
英文名称:
Uridine 5'-(trihydrogendiphosphate), P'-[2-(acetylamino)-2-deoxy-a-D-glucopyranosyl] ester
分子式:
C17H27N3O17P2
分子量:
607.353707551956

尿苷 5'-(2-乙酰氨基-2-脱氧-ALPHA-D-葡糖基焦磷酸酯)(528-04-1)名称与标识符

名称

中文别名:
尿苷 5'-(2-乙酰氨基-2-脱氧-ALPHA-D-葡糖基焦磷酸酯);
英文别名:
Uridine 5'-(trihydrogendiphosphate), P'-[2-(acetylamino)-2-deoxy-a-D-glucopyranosyl] ester;UDP-N-ACETYL-D-GLUCOSAMINE;UDP-N-acetyl-glucosamine;UDP N-acetyl-alpha-D-glucosamine;UDP-alpha-D-N-acetylglucosamine;[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] hydrogen phosphate;uridine diphosphate N-acetylglucosamine;DTXSID10912327;[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate;bmse000188;Udp acetylglucosamine;Uridine 5'-(trihydrogen diphosphate), P'-(2-(acetylamino)-2-deoxy-alpha-D-glucopyranosyl) ester;Acetylglucosamine, UDP;Uridine diphosphate-N-acetylglucosamine;528-04-1;Udpgnac;Uridine pyrophosphoacetylglucosamine;Uridine diphospho-N-acetylglucosamine;SCHEMBL1521296;Uridine 5'-Diphospho-N-Acetlyglucosamine;UDP-N-acetylglucosamine;URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE;Uridine diphosphate N-acetyl-D-glucosamine;Uridine diphosphoacetylglucosamine;UDP-acetyl-D-glucosamine;DB03397;91183-98-1;UDP N-acetyl-glucosamine;UDP-acetyl-delta-glucosamine;UPPAG;Q312208;A-D-N-acetylglucosamine;{[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]phosphinic acid;(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name);Udpx;Uridine 5'-diphospho-N-acetylglucosamine;UDP-N-acetyl-alpha-D-glucosamine;UDP-;[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate;Uridine diphospho-N-acetyl-D-glucosamine;C00043;Uridine diphospho-2-acetamido-2-deoxy-delta-glucose;Uridine diphospho-2-acetamido-2-deoxy-D-glucose;Uridine diphospho-N-acetyl-delta-glucosamine;uridine 5'-[3-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl) dihydrogen diphosphate];NS00015645;LFTYTUAZOPRMMI-CFRASDGPSA-N;[[3-acetylamino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl]oxy-[[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy]phosphinic acid;UDP-a-D-N-acetylglucosamine;[[3-acetylamino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl]oxy-[[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy]phosphinate;Uridine pyrophosphate 2-acetamido-2-deoxy-a-D-glucopyranosyl ester;N-[2-[[[5-[(2,4-dioxo-1H-pyrimidin-1-yl)]-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphinoyl]oxy-hydroxy-phosphinoyl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]acetamide;Uridine pyrophosphate 2-acetamido-2-deoxy-alpha-D-glucopyranosyl ester;UDP-GlcNAc;CHEMBL388154;UDP-N-acetyl-delta-glucosamine;CHEBI:16264;UDP-alpha-delta-N-acetylglucosamine;Uridine diphosphate N-acetyl-delta-glucosamine;GTPL1779;J-700272;Uridine pyrophosphate 2-acetamido-2-deoxy-alpha-delta-glucopyranosyl ester;UD1;UDP-acetylglucosamine;[[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy;

标识符

InChIKey:
LFTYTUAZOPRMMI-UBDZBXRQSA-N
Inchi:
1S/C17H27N3O17P2/c1-6(22)18-10-13(26)11(24)7(4-21)35-16(10)36-39(31,32)37-38(29,30)33-5-8-12(25)14(27)15(34-8)20-3-2-9(23)19-17(20)28/h2-3,7-8,10-16,21,24-27H,4-5H2,1H3,(H,18,22)(H,29,30)(H,31,32)(H,19,23,28)/t7-,8-,10-,11-,12-,13-,14-,15-,16+/m1/s1
SMILES:
P(=O)(O)(OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@H](N2C=CC(NC2=O)=O)O1)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)NC(C)=O

尿苷 5'-(2-乙酰氨基-2-脱氧-ALPHA-D-葡糖基焦磷酸酯)(528-04-1)物化性质

实验特性

  • 溶解度 : 溶解 (85 g/L) (25 ºC),
  • 密度 : 1.86±0.1 g/cm3 (20 ºC 760 Torr),

计算特性

  • 精确分子量 : 607.08157040g/mol
  • 氢键供体数量 : 9
  • 氢键受体数量 : 17
  • 可旋转化学键数量 : 10
  • 同位素质量 : 607.08157040g/mol
  • 重原子数量 : 39
  • 复杂度 : 1080
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 9
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -6.6
  • 拓扑分子极性表面积 : 300Ų

尿苷 5'-(2-乙酰氨基-2-脱氧-ALPHA-D-葡糖基焦磷酸酯)(528-04-1)推荐厂家 更多厂家(3)

公司名称手机号/电话联系人QQ微信询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
杭州六可生物科技有限公司 15658003402
0086-571-86912261
Susan 3671025517
询单
上海阿拉丁生化科技股份有限公司 13167063860
13167063860
阿拉丁 3004013043
询单

尿苷 5'-(2-乙酰氨基-2-脱氧-ALPHA-D-葡糖基焦磷酸酯)(528-04-1)相关文献